000 01837 a2200505 4500
005 20250517004835.0
264 0 _c20151009
008 201510s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/srep07201
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKang, Hyo Jin
245 0 0 _aHER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction.
_h[electronic resource]
260 _bScientific reports
_cDec 2014
300 _a7201 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntioxidant Response Elements
_xgenetics
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Line
650 0 4 _aDNA-Binding Proteins
_xgenetics
650 0 4 _aDoxorubicin
_xpharmacology
650 0 4 _aDrug Resistance, Neoplasm
_xgenetics
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHEK293 Cells
650 0 4 _aHeme Oxygenase-1
_xgenetics
650 0 4 _aHumans
650 0 4 _aMCF-7 Cells
650 0 4 _aMultidrug Resistance-Associated Proteins
_xgenetics
650 0 4 _aNF-E2-Related Factor 2
_xgenetics
650 0 4 _aParaquat
_xpharmacology
650 0 4 _aReceptor, ErbB-2
_xgenetics
650 0 4 _aTranscription, Genetic
_xdrug effects
650 0 4 _aTranscriptional Activation
_xdrug effects
650 0 4 _aTumor Cells, Cultured
650 0 4 _aUp-Regulation
_xdrug effects
700 1 _aYi, Yong Weon
700 1 _aHong, Young Bin
700 1 _aKim, Hee Jeong
700 1 _aJang, Young-Joo
700 1 _aSeong, Yeon-Sun
700 1 _aBae, Insoo
773 0 _tScientific reports
_gvol. 4
_gp. 7201
856 4 0 _uhttps://doi.org/10.1038/srep07201
_zAvailable from publisher's website
999 _c24421177
_d24421177